Pro Medicus Limited ( (AU:PME) ) has issued an update.
Pro Medicus Limited announced the cessation of 2,520 ordinary fully paid securities as part of an on-market buy-back, effective April 1, 2025. This move is part of the company’s capital management strategy, potentially impacting its stock liquidity and shareholder value positively by reducing the number of shares outstanding.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare industry, providing advanced imaging and information technology solutions primarily for radiology departments. The company focuses on delivering innovative software solutions that enhance medical imaging and streamline healthcare workflows.
YTD Price Performance: -19.26%
Average Trading Volume: 479
Technical Sentiment Signal: Sell
Current Market Cap: $13.03B
Find detailed analytics on PME stock on TipRanks’ Stock Analysis page.